North Cell Pharmaceutical has developed a technology platform of patented ingredients (Skin Resuscitation Factor™ SRF™) that can down regulate inflammation (eliminate the destruction of nitric oxide to peroxynitrite), to enhance healing or to up regulate nitric oxide that can be used by the human body to kill bacterial, viral, and fungal infections and tumors. SRF™ can be used independently to create new products or can be added to existing products to enhance efficacy and to generate new product claims.
North Cell and GlaxoSmithKline Sign Agreement North Cell Pharmaceutical, Inc. and GlaxoSmithKline Consumer Healthcare have entered into an Option and Development Agreement regarding North Cell’s Skin Resuscitation FactorTM (SRFTM ) technology for use in certain applications. . .
North Cell Granted New Patent On Anti-Cancer Compound Immunostimulator anti-cancer compounds and methods for their use in the treatment of cancer
Market Data 
Markets 
